| Title |
Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children
|
|---|---|
| Published in |
Drug Safety, November 2012
|
| DOI | 10.2165/11592020-000000000-00000 |
| Pubmed ID | |
| Authors |
Tamara Pringsheim, Darren Lam, Heidi Ching, Scott Patten |
| Abstract |
Available evidence indicates that the use of antipsychotics, especially second-generation antipsychotics (SGAs), for children with mental health disorders has increased dramatically. Given the demonstrated metabolic and neurological adverse effects seen in adult patients on these medications, detailed evaluation of the risk for these adverse effects in children is appropriate. |
Mendeley readers
The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| United States | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 122 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 16% |
| Student > Bachelor | 15 | 12% |
| Researcher | 14 | 11% |
| Other | 12 | 10% |
| Student > Ph. D. Student | 10 | 8% |
| Other | 29 | 23% |
| Unknown | 26 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 30% |
| Psychology | 19 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 8% |
| Neuroscience | 8 | 6% |
| Nursing and Health Professions | 5 | 4% |
| Other | 18 | 14% |
| Unknown | 28 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2011.
All research outputs
#6,323,800
of 25,373,627 outputs
Outputs from Drug Safety
#709
of 1,852 outputs
Outputs of similar age
#59,941
of 285,354 outputs
Outputs of similar age from Drug Safety
#316
of 812 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,354 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.